Clinical predictors of survival in advanced epithelial ovarian cancer: Can we foresee the long-term survivors and develop a personalized treatment approach?
We are 90% funded by individual contributions. That means you create the reader-powered journalism that cuts through the noise, and delivers the trusted information Connecticut cares about. During its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback